<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638024</url>
  </required_header>
  <id_info>
    <org_study_id>Cell free fetal DNA</org_study_id>
    <nct_id>NCT03638024</nct_id>
  </id_info>
  <brief_title>Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .</brief_title>
  <official_title>Predictive Value of Cell-free Fetal DNA Concentration in the Maternal Plasma for Abnormal Placental Invasion in Cases of Placenta Previa.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cell free fetal DNA might predict abnormal placental invasion
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to evaluate whether measurement of cell-free fetal DNA in the maternal plasma
      can be predictive of abnormal invasion in cases of placenta previa.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">April 3, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 3, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predictive value of maternal plasma cell free DNA</measure>
    <time_frame>4 months</time_frame>
    <description>Prediction of abnormal placental invasion in cases of placenta previa.
Primary aim: Is to evaluate whether measurement of cell-free fetal DNA in the maternal plasma can be predictive of abnormal placental invasion in cases of placenta previa.
Secondary aim: To decrease maternal morbidity and mortality by early prenatal diagnosis of abnormal placental invasion in placenta previa</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>maternal morbidity</measure>
    <time_frame>4 months</time_frame>
    <description>maternal morbidity</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Placenta Accreta</condition>
  <condition>Placenta Percreta</condition>
  <condition>Placenta Increta</condition>
  <condition>Placenta Previa</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>Maternal plasma cell free fetal DNA levels will be measured in 25 women with one or more previous cesarean section and placenta previa anterior only or with ultrasound finding suggestive of placental adhesion or invasion (accreta , increta or percreta).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Maternal plasma cell free fetal DNA levels will be measured in 25 matched control with normally situated placenta without ultrasound finding suggestive of placental adhesion or invasion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Maternal plasma cell free fetal DNA levels</intervention_name>
    <description>Measurement Maternal plasma cell free fetal DNA levels in both groups (study and control groups)</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study group (1): 25 women with one or more previous cesarean section and placenta previa
        anterior only or with ultrasound finding suggestive of placental adhesion or invasion
        (accreta , increta or percreta).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Maternal age range from 20-40 years old.

          2. Parity: para 1- para 5.

          3. Body mass index range from 18-25 kg/m2.

          4. Singleton pregnancy carrying male fetuses.

          5. Gestational age range from 28-34 weeks.

        Exclusion criteria:

          1. Multifetal pregnancy.

          2. Hypertension, preterm labor and intrauterine growth restriction.

          3. Patients taking a tocolytic agent or those with uterine bleeding at or after blood
             sampling.

               -  Since these complications may increase the level of cell-free fetal DNA.

          4. Accidental hemorrhage.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams University, Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina Mansour</last_name>
      <phone>+20100657</phone>
      <email>Dinayahiamansour@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>October 5, 2018</last_update_submitted>
  <last_update_submitted_qc>October 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Dr- dina yahia mansour</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and Gynecology Ain Shams University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Previa</mesh_term>
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

